Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Size & Outlook
The cell & gene therapy bioanalytical testing services market in Saudi Arabia is expected to reach a projected revenue of US$ 6.2 million by 2030. A compound annual growth rate of 3.8% is expected of Saudi Arabia cell & gene therapy bioanalytical testing services market from 2024 to 2030.
Revenue, 2023 (US$M)
$4.8
Forecast, 2030 (US$M)
$6.2
CAGR, 2024 - 2030
3.7%
Report Coverage
Saudi Arabia
Saudi Arabia cell & gene therapy bioanalytical testing services market, 2018-2030 (US$M)
Related Markets
Saudi Arabia cell & gene therapy bioanalytical testing services market highlights
- The Saudi Arabia cell & gene therapy bioanalytical testing services market generated a revenue of USD 4.8 million in 2023 and is expected to reach USD 6.2 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 3.8% from 2024 to 2030.
- In terms of segment, bioavailability & bioequivalence studies was the largest revenue generating test type in 2023.
- Bioavailability & Bioequivalence Studies is the most lucrative test type segment registering the fastest growth during the forecast period.
Cell & gene therapy bioanalytical testing services market data book summary
| Market revenue in 2023 | USD 4.8 million |
| Market revenue in 2030 | USD 6.2 million |
| Growth rate | 3.8% (CAGR from 2023 to 2030) |
| Largest segment | Bioavailability & bioequivalence studies |
| Fastest growing segment | Bioavailability & Bioequivalence Studies |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Other test type |
| Key market players worldwide | IQVIA Holdings Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, Charles River Laboratories International Inc, Syneos Health, Intertek Group PLC |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.9% of the global cell & gene therapy bioanalytical testing services market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia cell & gene therapy bioanalytical testing services market is projected to lead the regional market in terms of revenue in 2030.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 5.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell & Gene Therapy Bioanalytical Testing Services Market Scope
Cell & gene therapy bioanalytical testing services market segmentation & scope
Bioavailability & Bioequivalence Studies
Pharmacokinetics
Pharmacodynamics
Other test type
Ex-vivo
In-vivo
CAR T-cell therapies
CAR-NK cell therapy
TCR-T cell therapy
Other
Cell Therapy
Gene Therapy
Gene-Modified Cell Therapy
Cell Therapy
Gene Therapy
Gene-Modified Cell Therapy
Cell Therapy
Cell & Gene Therapy Bioanalytical Testing Services Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia cell & gene therapy bioanalytical testing services market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell & gene therapy bioanalytical testing services market will help companies and investors design strategic landscapes.
Bioavailability & bioequivalence studies was the largest segment with a revenue share of 35.42% in 2023. Horizon Databook has segmented the Saudi Arabia cell & gene therapy bioanalytical testing services market based on bioavailability & bioequivalence studies, pharmacokinetics, pharmacodynamics, other test type covering the revenue growth of each sub-segment from 2018 to 2030.
- Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Test Type Outlook (Revenue, USD million, 2018-2030)
- Bioavailability & Bioequivalence Studies
- Pharmacokinetics
- Pharmacodynamics
- Other test type
- Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Product Outlook (Revenue, USD million, 2018-2030)
- Gene Therapy
- Ex-vivo
- In-vivo
- Gene-Modified Cell Therapy
- CAR T-cell therapies
- CAR-NK cell therapy
- TCR-T cell therapy
- Other
- Cell Therapy
- Gene Therapy
- Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Stage of Development Outlook (Revenue, USD million, 2018-2030)
- Non-Clinical
- Gene Therapy
- Gene-Modified Cell Therapy
- Cell Therapy
- Clinical
- Gene Therapy
- Gene-Modified Cell Therapy
- Cell Therapy
- Non-Clinical
- Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Indication Outlook (Revenue, USD million, 2018-2030)
- Oncology
- Infectious Diseases
- Neurological disorders
- Rare Diseases
- Others
Reasons to subscribe to Saudi Arabia cell & gene therapy bioanalytical testing services market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia cell & gene therapy bioanalytical testing services market databook
-
Our clientele includes a mix of cell & gene therapy bioanalytical testing services market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia cell & gene therapy bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia cell & gene therapy bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia cell & gene therapy bioanalytical testing services market size, by test type, 2018-2030 (US$M)
Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
